Zoe Arvanitakis1, Robin L Brey2, Jacob H Rand2

  • 1From the Rush Alzheimer's Disease Center (Z.A., J.A.S., A.W.C., L.Y., S.E.L., D.A.B.), Department of Neurological Sciences (Z.A., J.A.S., A.W.C., L.Y., S.E.L., D.A.B.), and Department of Pathology (J.A.S.), Rush University Medical Center, Chicago, IL; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio (R.L.B.); Department of Pathology, Montefiore Medical Center, Bronx, NY (J.H.R.); and Departments of Neurology and Emergency Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, and Department of Neurology, Kings County Hospital Center, Brooklyn, NY (S.R.L.). zarvanit@rush.edu.

Circulation
|October 11, 2014
PubMed
まとめ

アンチフォスフォリピド抗体 (aPLs) は,高齢者の脳梗塞のリスク増加と関連していません. この研究では,遺体解剖を受けたコミュニティに住む個人の病理的な脳梗塞とaPLを関連付ける証拠は見つかりませんでした.